Concise Review: Bipotent Megakaryocytic-Erythroid Progenitors: Concepts and Controversies
Overview
Reproductive Medicine
Affiliations
Hematopoietic stem and progenitor cells maintain blood formation throughout our lifetime by undergoing long- and short-term self-renewal, respectively. As progenitor cells progress through the hematopoiesis process, their differentiation capabilities narrow, such that the precursors become committed to only one or two lineages. This Review focuses on recent advances in the identification and characterization of bipotent megakaryocytic-erythroid progenitors (MEP), the cells that can further produce two completely different functional outputs: platelets and red blood cells. The existence of MEP has sparked controversy as studies describing the requirement for this intermediate progenitor stage prior to commitment to the erythroid and megakaryocytic lineages have been potentially contradictory. Interpretation of these studies is complicated by the variety of species, cell sources, and analytical approaches used along with inherent challenges in the continuum of hematopoiesis, where hematopoietic progenitors do not stop at discrete steps on single paths as classically drawn in hematopoietic hierarchy models. With the goal of improving our understanding of human hematopoiesis, we discuss findings in both human and murine cells. Based on these data, MEP clearly represent a transitional stage of differentiation in at least one route to the generation of both megakaryocytes and erythroid cells. Stem Cells 2018;36:1138-1145.
Tkachenko A, Havranek O Apoptosis. 2025; .
PMID: 39924584 DOI: 10.1007/s10495-025-02081-5.
The heart is a resident tissue for hematopoietic stem and progenitor cells in zebrafish.
Bornhorst D, Hejjaji A, Steuter L, Woodhead N, Maier P, Gentile A Nat Commun. 2024; 15(1):7589.
PMID: 39217144 PMC: 11366026. DOI: 10.1038/s41467-024-51920-7.
CDK9 phosphorylates RUNX1 to promote megakaryocytic fate in megakaryocytic-erythroid progenitors.
Kwon N, Lu Y, Thompson E, Mancuso R, Wang L, Zhang P Blood. 2024; 144(17):1800-1812.
PMID: 39102635 PMC: 11530366. DOI: 10.1182/blood.2024023963.
Lykins J, Becker I, Camacho V, Alfar H, Park J, Italiano J Blood Adv. 2024; 9(1):15-28.
PMID: 38941534 PMC: 11732581. DOI: 10.1182/bloodadvances.2024012995.
The role of GATA2 in adult hematopoiesis and cell fate determination.
Peters I, de Pater E, Zhang W Front Cell Dev Biol. 2023; 11:1250827.
PMID: 38033856 PMC: 10682726. DOI: 10.3389/fcell.2023.1250827.